1
|
The pathogenesis of rheumatoid arthritis.
|
N Engl J Med
|
2011
|
12.16
|
2
|
Cytokines in the pathogenesis of rheumatoid arthritis.
|
Nat Rev Immunol
|
2007
|
8.47
|
3
|
Dickkopf-1 is a master regulator of joint remodeling.
|
Nat Med
|
2007
|
7.29
|
4
|
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
|
J Clin Invest
|
2012
|
4.31
|
5
|
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.
|
Nature
|
2010
|
4.01
|
6
|
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
|
Arthritis Rheum
|
2007
|
3.02
|
7
|
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
|
J Exp Med
|
2008
|
2.97
|
8
|
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.
|
Nat Med
|
2013
|
2.93
|
9
|
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
|
J Clin Invest
|
2002
|
2.85
|
10
|
Regulatory T cells protect from local and systemic bone destruction in arthritis.
|
J Immunol
|
2010
|
2.70
|
11
|
Autophagy regulates TNFα-mediated joint destruction in experimental arthritis.
|
Ann Rheum Dis
|
2012
|
2.66
|
12
|
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis.
|
Nat Commun
|
2012
|
2.65
|
13
|
Prospective study on circulating MicroRNAs and risk of myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
2.59
|
14
|
Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography.
|
Arthritis Rheum
|
2010
|
2.54
|
15
|
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
|
Arthritis Rheumatol
|
2015
|
2.39
|
16
|
I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
|
J Exp Med
|
2005
|
2.21
|
17
|
Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis.
|
Medicine (Baltimore)
|
2009
|
2.14
|
18
|
Treg cells suppress osteoclast formation: a new link between the immune system and bone.
|
Arthritis Rheum
|
2007
|
2.12
|
19
|
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.
|
Circulation
|
2004
|
2.08
|
20
|
Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
|
Acta Diabetol
|
2014
|
2.07
|
21
|
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY).
|
Ann Rheum Dis
|
2012
|
2.06
|
22
|
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance.
|
Immunity
|
2012
|
2.06
|
23
|
Platelet-derived serotonin links vascular disease and tissue fibrosis.
|
J Exp Med
|
2011
|
2.05
|
24
|
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus.
|
Arthritis Rheum
|
2009
|
2.04
|
25
|
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.
|
Proc Natl Acad Sci U S A
|
2011
|
1.95
|
26
|
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
|
Arthritis Rheum
|
2004
|
1.94
|
27
|
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
|
Ann Rheum Dis
|
2014
|
1.88
|
28
|
Detection of "Candidatus Neoehrlichia mikurensis" in two patients with severe febrile illnesses: evidence for a European sequence variant.
|
J Clin Microbiol
|
2010
|
1.82
|
29
|
Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
|
Ann Rheum Dis
|
2012
|
1.81
|
30
|
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis.
|
Ann Rheum Dis
|
2012
|
1.78
|
31
|
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.
|
Rheumatology (Oxford)
|
2011
|
1.74
|
32
|
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
|
Arthritis Rheum
|
2002
|
1.72
|
33
|
Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?
|
Arthritis Rheum
|
2013
|
1.69
|
34
|
Risk of infections in rheumatoid arthritis patients treated with tocilizumab.
|
Rheumatology (Oxford)
|
2011
|
1.68
|
35
|
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression.
|
Ann Rheum Dis
|
2010
|
1.67
|
36
|
PPARβ/δ governs Wnt signaling and bone turnover.
|
Nat Med
|
2013
|
1.66
|
37
|
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
|
Arthritis Rheum
|
2009
|
1.65
|
38
|
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis.
|
Arthritis Rheum
|
2007
|
1.62
|
39
|
TNF-induced structural joint damage is mediated by IL-1.
|
Proc Natl Acad Sci U S A
|
2007
|
1.61
|
40
|
Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis.
|
Arthritis Rheum
|
2013
|
1.59
|
41
|
Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?
|
Ann Rheum Dis
|
2007
|
1.58
|
42
|
Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis.
|
Ann Rheum Dis
|
2012
|
1.58
|
43
|
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
|
Ann Rheum Dis
|
2013
|
1.57
|
44
|
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
|
Ann Rheum Dis
|
2011
|
1.56
|
45
|
T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway.
|
Sci Transl Med
|
2014
|
1.56
|
46
|
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
|
Arthritis Rheum
|
2004
|
1.53
|
47
|
Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus.
|
Rheumatology (Oxford)
|
2010
|
1.53
|
48
|
Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
|
J Bone Miner Res
|
2012
|
1.49
|
49
|
Segmentation and quantification of bone erosions in high-resolution peripheral quantitative computed tomography datasets of the metacarpophalangeal joints of patients with rheumatoid arthritis.
|
Rheumatology (Oxford)
|
2013
|
1.48
|
50
|
Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
|
Arthritis Rheumatol
|
2014
|
1.48
|
51
|
Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis.
|
Ann Rheum Dis
|
2013
|
1.47
|
52
|
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
|
Arthritis Rheum
|
2009
|
1.40
|
53
|
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
|
Nat Med
|
2005
|
1.39
|
54
|
Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity.
|
Arthritis Care Res (Hoboken)
|
2012
|
1.37
|
55
|
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
|
Arthritis Rheum
|
2009
|
1.36
|
56
|
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.
|
Ann Rheum Dis
|
2013
|
1.36
|
57
|
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
|
Expert Rev Cardiovasc Ther
|
2006
|
1.34
|
58
|
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.
|
FASEB J
|
2008
|
1.33
|
59
|
Anaemia in inflammatory rheumatic diseases.
|
Nat Rev Rheumatol
|
2012
|
1.33
|
60
|
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.
|
Ann Rheum Dis
|
2014
|
1.27
|
61
|
The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis.
|
Semin Arthritis Rheum
|
2012
|
1.27
|
62
|
12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis.
|
J Immunol
|
2009
|
1.27
|
63
|
β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
|
Ann Rheum Dis
|
2012
|
1.25
|
64
|
Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion.
|
Ann Rheum Dis
|
2011
|
1.25
|
65
|
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
|
Am J Pathol
|
2004
|
1.24
|
66
|
Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis.
|
J Immunol
|
2005
|
1.24
|
67
|
Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
|
Circulation
|
2007
|
1.23
|
68
|
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
|
Arthritis Rheum
|
2007
|
1.23
|
69
|
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.
|
Arthritis Res Ther
|
2011
|
1.22
|
70
|
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
1.21
|
71
|
Sodium overload and water influx activate the NALP3 inflammasome.
|
J Biol Chem
|
2010
|
1.20
|
72
|
Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
1.20
|
73
|
Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
|
Arthritis Rheum
|
2008
|
1.20
|
74
|
Animal models for arthritis: innovative tools for prevention and treatment.
|
Ann Rheum Dis
|
2011
|
1.20
|
75
|
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis.
|
J Cell Sci
|
2009
|
1.19
|
76
|
Pathways for bone loss in inflammatory disease.
|
Curr Osteoporos Rep
|
2012
|
1.19
|
77
|
Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis.
|
Arthritis Rheum
|
2007
|
1.19
|
78
|
IgG4 immune response in Churg-Strauss syndrome.
|
Ann Rheum Dis
|
2011
|
1.18
|
79
|
Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
|
Arthritis Rheum
|
2006
|
1.17
|
80
|
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
|
Arthritis Rheum
|
2003
|
1.17
|
81
|
Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.
|
Autoimmun Rev
|
2010
|
1.17
|
82
|
Animal models of systemic sclerosis: prospects and limitations.
|
Arthritis Rheum
|
2010
|
1.16
|
83
|
Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis.
|
Arthritis Rheum
|
2008
|
1.16
|
84
|
Spondyloarthritis: may the force be with you?
|
Ann Rheum Dis
|
2013
|
1.15
|
85
|
Pathogenesis of rheumatoid arthritis: targeting cytokines.
|
Ann N Y Acad Sci
|
2005
|
1.15
|
86
|
Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice.
|
Proc Natl Acad Sci U S A
|
2013
|
1.14
|
87
|
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
|
Trends Mol Med
|
2008
|
1.14
|
88
|
Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
|
Arthritis Rheum
|
2010
|
1.14
|
89
|
Autoimmunity's next top models.
|
Nat Med
|
2012
|
1.14
|
90
|
The interaction of physical function and emotional well-being in rheumatoid arthritis--what is the impact on disease activity and coping?
|
Semin Arthritis Rheum
|
2013
|
1.13
|
91
|
Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients.
|
Semin Arthritis Rheum
|
2008
|
1.12
|
92
|
IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss.
|
J Immunol
|
2011
|
1.12
|
93
|
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
|
J Bone Miner Res
|
2005
|
1.11
|
94
|
CD44 is a determinant of inflammatory bone loss.
|
J Exp Med
|
2005
|
1.10
|
95
|
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation.
|
J Bone Miner Res
|
2004
|
1.09
|
96
|
Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cells.
|
Front Immunol
|
2012
|
1.09
|
97
|
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production.
|
J Bone Miner Res
|
2012
|
1.08
|
98
|
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
|
Ann Rheum Dis
|
2011
|
1.07
|
99
|
The controversial role of tumor necrosis factor alpha in fibrotic diseases.
|
Arthritis Rheum
|
2008
|
1.06
|
100
|
Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis.
|
Arthritis Res Ther
|
2009
|
1.06
|
101
|
The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss.
|
J Immunol
|
2009
|
1.06
|
102
|
Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles.
|
J Biol Chem
|
2011
|
1.05
|
103
|
Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals.
|
Front Immunol
|
2012
|
1.04
|
104
|
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption.
|
FASEB J
|
2005
|
1.04
|
105
|
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis.
|
Ann Rheum Dis
|
2010
|
1.04
|
106
|
R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway.
|
Arthritis Rheum
|
2010
|
1.03
|
107
|
Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.
|
Arthritis Rheum
|
2010
|
1.03
|
108
|
Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling.
|
Arthritis Rheum
|
2009
|
1.02
|
109
|
The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes.
|
Ann Rheum Dis
|
2012
|
1.02
|
110
|
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
|
Arthritis Res Ther
|
2009
|
1.02
|
111
|
Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study.
|
Stroke
|
2005
|
1.02
|
112
|
Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
|
J Bone Miner Res
|
2011
|
1.02
|
113
|
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
|
Circulation
|
2009
|
1.02
|
114
|
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
|
Eur J Immunol
|
2012
|
1.01
|
115
|
Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo.
|
Arthritis Res Ther
|
2005
|
1.01
|
116
|
Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis.
|
Autoimmunity
|
2009
|
1.01
|
117
|
A detailed comparative study of high-resolution ultrasound and micro-computed tomography for detection of arthritic bone erosions.
|
Arthritis Rheum
|
2011
|
1.01
|
118
|
Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.
|
Arthritis Rheum
|
2008
|
1.00
|
119
|
Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
|
Arthritis Rheum
|
2011
|
1.00
|
120
|
Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.
|
Rheumatol Int
|
2011
|
1.00
|
121
|
JNK1 is not essential for TNF-mediated joint disease.
|
Arthritis Res Ther
|
2004
|
0.99
|
122
|
Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.
|
J Immunol
|
2009
|
0.99
|
123
|
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.
|
Ann Rheum Dis
|
2013
|
0.99
|
124
|
Elevated Fra-1 expression causes severe lipodystrophy.
|
J Cell Sci
|
2011
|
0.99
|
125
|
High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
|
Eur J Immunol
|
2011
|
0.98
|
126
|
The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium.
|
Ann Rheum Dis
|
2012
|
0.98
|
127
|
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis.
|
Arthritis Rheum
|
2012
|
0.96
|
128
|
Combining functional magnetic resonance imaging with mouse genomics: new options in pain research.
|
Neuroreport
|
2010
|
0.96
|
129
|
Design of the tocilizumab in giant cell arteritis trial.
|
Int J Rheumatol
|
2013
|
0.96
|
130
|
Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study.
|
Ann Rheum Dis
|
2012
|
0.96
|
131
|
CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.
|
Arthritis Rheum
|
2010
|
0.95
|
132
|
B-cell infiltrates induce endosteal bone formation in inflammatory arthritis.
|
J Bone Miner Res
|
2008
|
0.95
|
133
|
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death.
|
Innate Immun
|
2012
|
0.95
|
134
|
Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
|
Arthritis Rheum
|
2012
|
0.95
|
135
|
Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts.
|
J Cell Mol Med
|
2011
|
0.95
|
136
|
Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.
|
Arthritis Rheum
|
2009
|
0.95
|
137
|
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.
|
Arthritis Rheum
|
2009
|
0.95
|
138
|
CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation.
|
Front Immunol
|
2011
|
0.95
|
139
|
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.
|
Arthritis Rheum
|
2011
|
0.94
|
140
|
Redox modulation of HMGB1-related signaling.
|
Antioxid Redox Signal
|
2013
|
0.94
|
141
|
The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
|
Arthritis Rheum
|
2010
|
0.94
|
142
|
TNF and bone.
|
Curr Dir Autoimmun
|
2010
|
0.93
|
143
|
Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
|
Arthritis Rheum
|
2010
|
0.93
|
144
|
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis.
|
Ann Rheum Dis
|
2012
|
0.93
|
145
|
Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis.
|
Ann Rheum Dis
|
2011
|
0.93
|
146
|
Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.
|
Neoplasia
|
2010
|
0.92
|
147
|
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis.
|
Ann Rheum Dis
|
2013
|
0.92
|
148
|
Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance.
|
Eur J Immunol
|
2011
|
0.92
|
149
|
Vitamin D receptor regulates TNF-mediated arthritis.
|
Ann Rheum Dis
|
2011
|
0.91
|
150
|
The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
|
J Immunol
|
2007
|
0.91
|
151
|
Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players.
|
Apoptosis
|
2010
|
0.91
|
152
|
Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects.
|
Clin Rev Allergy Immunol
|
2005
|
0.90
|
153
|
NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.
|
Proc Natl Acad Sci U S A
|
2013
|
0.90
|
154
|
Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.
|
Arthritis Rheum
|
2008
|
0.90
|
155
|
IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
|
Semin Arthritis Rheum
|
2012
|
0.90
|
156
|
Moonlighting osteoclasts as undertakers of apoptotic cells.
|
Autoimmunity
|
2012
|
0.90
|
157
|
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling.
|
Ann Rheum Dis
|
2012
|
0.90
|
158
|
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.
|
Best Pract Res Clin Rheumatol
|
2010
|
0.89
|
159
|
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.
|
Ann Rheum Dis
|
2012
|
0.89
|
160
|
Serum Dkk-1 levels of DISH patients are not different from healthy controls.
|
Joint Bone Spine
|
2011
|
0.89
|
161
|
The lonely death: chondrocyte apoptosis in TNF-induced arthritis.
|
Autoimmunity
|
2007
|
0.89
|
162
|
Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.
|
Clin Rheumatol
|
2010
|
0.88
|
163
|
The uptake by blood-borne phagocytes of monosodium urate is dependent on heat-labile serum factor(s) and divalent cations.
|
Autoimmunity
|
2010
|
0.88
|
164
|
Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
|
Arthritis Rheum
|
2013
|
0.88
|
165
|
Inflammation and destruction of the joints--the Wnt pathway.
|
Joint Bone Spine
|
2008
|
0.88
|
166
|
Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study.
|
J Bone Miner Res
|
2014
|
0.88
|
167
|
Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism.
|
J Cell Sci
|
2013
|
0.88
|
168
|
Overexpression of tumor necrosis factor causes bilateral sacroiliitis.
|
Arthritis Rheum
|
2004
|
0.88
|
169
|
The structural basis of MRI bone erosions: an assessment by microCT.
|
Ann Rheum Dis
|
2012
|
0.87
|
170
|
Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation.
|
Arthritis Rheum
|
2012
|
0.87
|
171
|
Pathogenesis of Churg-Strauss syndrome: recent insights.
|
Autoimmunity
|
2009
|
0.87
|
172
|
Arthritis and bone loss: a hen and egg story.
|
Curr Opin Rheumatol
|
2014
|
0.87
|
173
|
Cell-intrinsic NF-κB activation is critical for the development of natural regulatory T cells in mice.
|
PLoS One
|
2011
|
0.87
|
174
|
Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption.
|
Eur J Clin Invest
|
2011
|
0.87
|
175
|
Pathophysiology of spondyloarthritis.
|
Curr Rheumatol Rep
|
2011
|
0.86
|
176
|
Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins.
|
Biochem Biophys Res Commun
|
2008
|
0.86
|
177
|
Sodium and potassium urate crystals differ in their inflammatory potential.
|
Autoimmunity
|
2009
|
0.86
|
178
|
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
|
Hum Mol Genet
|
2011
|
0.86
|
179
|
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
|
Ann Rheum Dis
|
2012
|
0.85
|
180
|
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
|
Ann Rheum Dis
|
2012
|
0.85
|
181
|
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
|
Arthritis Res Ther
|
2006
|
0.85
|
182
|
Inhibition of sumoylation prevents experimental fibrosis.
|
Ann Rheum Dis
|
2012
|
0.85
|
183
|
The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis.
|
Ann Rheum Dis
|
2011
|
0.85
|
184
|
The Wnt antagonist Wif-1 interacts with CTGF and inhibits CTGF activity.
|
J Cell Physiol
|
2012
|
0.85
|
185
|
B cells are critical for autoimmune pathology in Scurfy mice.
|
Proc Natl Acad Sci U S A
|
2013
|
0.85
|
186
|
MoMa from patients with systemic lupus erythematosus show altered adhesive activity.
|
Autoimmunity
|
2009
|
0.85
|
187
|
Musculoskeletal disease burden of hereditary hemochromatosis.
|
Arthritis Rheum
|
2010
|
0.85
|
188
|
Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
|
Ann Rheum Dis
|
2010
|
0.84
|
189
|
Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease.
|
Ann Rheum Dis
|
2011
|
0.84
|
190
|
Synovial immunopathology in haemochromatosis arthropathy.
|
Ann Rheum Dis
|
2009
|
0.84
|
191
|
PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis.
|
FASEB J
|
2009
|
0.84
|
192
|
Pathophysiology of new bone formation and ankylosis in spondyloarthritis.
|
Rheum Dis Clin North Am
|
2012
|
0.84
|
193
|
UVB-irradiated apoptotic cells induce accelerated growth of co-implanted viable tumor cells in immune competent mice.
|
Autoimmunity
|
2013
|
0.84
|
194
|
Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis.
|
Arthritis Rheum
|
2013
|
0.84
|
195
|
Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.
|
Ann Rheum Dis
|
2012
|
0.83
|
196
|
Treatment with DNAse I fosters binding to nec PBMC of CRP.
|
Autoimmunity
|
2009
|
0.83
|
197
|
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis.
|
Ann Rheum Dis
|
2012
|
0.83
|
198
|
Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo.
|
J Cell Mol Med
|
2009
|
0.83
|
199
|
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.
|
Arthritis Rheum
|
2010
|
0.83
|
200
|
T cells as key players for bone destruction in gouty arthritis?
|
Arthritis Res Ther
|
2011
|
0.83
|
201
|
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis.
|
Ann Rheum Dis
|
2012
|
0.83
|
202
|
Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.
|
Clin Rheumatol
|
2011
|
0.83
|
203
|
RSK2 protects mice against TNF-induced bone loss.
|
J Cell Sci
|
2012
|
0.83
|
204
|
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis.
|
Ann Rheum Dis
|
2012
|
0.83
|
205
|
12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function.
|
J Clin Invest
|
2015
|
0.83
|
206
|
Ucma is not necessary for normal development of the mouse skeleton.
|
Bone
|
2011
|
0.82
|
207
|
Standardization of joint examination technique leads to a significant decrease in variability among different examiners.
|
J Rheumatol
|
2010
|
0.82
|
208
|
Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled study.
|
J Rheumatol
|
2013
|
0.82
|
209
|
Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus.
|
Glycobiology
|
2012
|
0.82
|
210
|
Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritis.
|
Arthritis Rheumatol
|
2014
|
0.82
|
211
|
Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophy.
|
Arthritis Rheum
|
2008
|
0.82
|
212
|
Bone histomorphometry in arthritis models.
|
Methods Mol Med
|
2007
|
0.81
|
213
|
Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
|
Arthritis Rheum
|
2008
|
0.81
|
214
|
Differences in the patient's and the physician's perspective of disease in psoriatic arthritis.
|
Semin Arthritis Rheum
|
2012
|
0.81
|
215
|
Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers.
|
Arthritis Res Ther
|
2013
|
0.81
|
216
|
Induction of apoptosis in circulating angiogenic cells by microparticles.
|
Arthritis Rheum
|
2011
|
0.81
|
217
|
Osteoclasts and Arthritis.
|
J Bone Miner Res
|
2009
|
0.81
|
218
|
Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus.
|
Ann Rheum Dis
|
2010
|
0.81
|
219
|
The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells.
|
J Immunol
|
2014
|
0.81
|
220
|
Transcription factor Fra-1 induces cholangitis and liver fibrosis.
|
Hepatology
|
2011
|
0.81
|
221
|
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
|
Arthritis Rheumatol
|
2014
|
0.80
|
222
|
How neutrophil extracellular traps orchestrate the local immune response in gout.
|
J Mol Med (Berl)
|
2015
|
0.80
|
223
|
ACPA and bone loss in rheumatoid arthritis.
|
Curr Rheumatol Rep
|
2013
|
0.80
|
224
|
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
|
Ann Rheum Dis
|
2013
|
0.80
|
225
|
The 12/15-lipoxygenase pathway promotes osteoclast development and differentiation.
|
Autoimmunity
|
2009
|
0.80
|
226
|
IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE.
|
Autoimmunity
|
2010
|
0.80
|
227
|
Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover.
|
J Bone Miner Res
|
2013
|
0.80
|
228
|
Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis.
|
Rheumatology (Oxford)
|
2013
|
0.80
|
229
|
Autoantibody-mediated bone loss.
|
Curr Osteoporos Rep
|
2014
|
0.80
|
230
|
Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study.
|
Rheumatology (Oxford)
|
2013
|
0.80
|
231
|
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
|
Arthritis Rheum
|
2008
|
0.80
|
232
|
Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
|
Arthritis Rheum
|
2011
|
0.79
|
233
|
JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.
|
Arthritis Rheum
|
2012
|
0.79
|
234
|
Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
|
Arthritis Rheum
|
2010
|
0.79
|
235
|
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.
|
J Craniomaxillofac Surg
|
2012
|
0.79
|
236
|
Running has a negative effect on bone metabolism and proinflammatory status in male aged rats.
|
Exp Gerontol
|
2008
|
0.79
|
237
|
Hereditary hemochromatosis as a risk factor for joint replacement surgery.
|
Am J Med
|
2010
|
0.79
|
238
|
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling.
|
Ann Rheum Dis
|
2013
|
0.79
|
239
|
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
|
Ann Rheum Dis
|
2014
|
0.79
|
240
|
Clinical Images: Hippokrates confirmed by positron emission tomography.
|
Arthritis Rheum
|
2011
|
0.78
|
241
|
Anti-tumour necrosis factor alpha therapy in patients with impaired renal function.
|
Ann Rheum Dis
|
2007
|
0.78
|
242
|
Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.
|
Blood
|
2012
|
0.78
|
243
|
Detection of low level cryoglobulins by flow cytometry.
|
Cytometry A
|
2012
|
0.78
|
244
|
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
|
Ann Rheum Dis
|
2012
|
0.78
|
245
|
Bone research in 2012: the ups and downs of bone in health and rheumatic disease.
|
Nat Rev Rheumatol
|
2013
|
0.78
|
246
|
Risk prediction for severe osteoarthritis.
|
Ann Rheum Dis
|
2010
|
0.78
|
247
|
The binding of sera of patients with SLE to bacterial and mammalian DNA.
|
Clin Immunol
|
2005
|
0.78
|
248
|
Definition for Rheumatoid Arthritis Erosions Imaged with High Resolution Peripheral Quantitative Computed Tomography and Interreader Reliability for Detection and Measurement.
|
J Rheumatol
|
2016
|
0.78
|
249
|
Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
|
J Immunol
|
2005
|
0.78
|
250
|
VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis.
|
Ann Rheum Dis
|
2013
|
0.77
|
251
|
Entheses and bones in spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
|
J Rheumatol
|
2009
|
0.77
|
252
|
Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review.
|
Semin Arthritis Rheum
|
2012
|
0.77
|
253
|
Registration of 2D histological sections with 3D micro-CT datasets from small animal vertebrae and tibiae.
|
Comput Methods Biomech Biomed Engin
|
2014
|
0.77
|
254
|
Activation of pregnane X receptor inhibits experimental dermal fibrosis.
|
Ann Rheum Dis
|
2013
|
0.77
|
255
|
Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.
|
BMC Musculoskelet Disord
|
2014
|
0.77
|
256
|
Characterization and quantification of angiogenesis in rheumatoid arthritis in a mouse model using μCT.
|
BMC Musculoskelet Disord
|
2014
|
0.77
|
257
|
Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy.
|
Arthritis Res Ther
|
2013
|
0.77
|
258
|
Inflammation-associated changes in bone homeostasis.
|
Inflamm Allergy Drug Targets
|
2012
|
0.77
|
259
|
Updating the OMERACT filter: implications for imaging and soluble biomarkers.
|
J Rheumatol
|
2014
|
0.77
|
260
|
Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
|
Am J Pathol
|
2012
|
0.77
|
261
|
Anti–citrullinated protein antibody positivity correlates with cartilage damage and proteoglycan levels in patients with rheumatoid arthritis in the hand joints.
|
Arthritis Rheumatol
|
2014
|
0.77
|
262
|
Do low vitamin D levels cause problems of waste removal in patients with SLE?
|
Rheumatology (Oxford)
|
2011
|
0.76
|
263
|
Increased expression of CD154 and FAS in SLE patients' lymphocytes.
|
Rheumatol Int
|
2009
|
0.76
|
264
|
The early marginal zone B cell-initiated T-independent type 2 response resists the proteasome inhibitor bortezomib.
|
J Immunol
|
2010
|
0.76
|
265
|
Coping strategies and depressiveness in primary systemic vasculitis--what is their impact on health-related quality of life?
|
Rheumatology (Oxford)
|
2013
|
0.76
|
266
|
Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele.
|
Autoimmunity
|
2012
|
0.75
|
267
|
Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis.
|
Ann Rheum Dis
|
2013
|
0.75
|
268
|
Denosumab, osteoporosis, and prevention of fractures.
|
N Engl J Med
|
2009
|
0.75
|
269
|
The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritis.
|
PLoS One
|
2013
|
0.75
|
270
|
A typically atypical tenosynovitis.
|
Clin Rheumatol
|
2010
|
0.75
|
271
|
A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors.
|
Ther Apher Dial
|
2008
|
0.75
|
272
|
Cardiomyopathy in murine models of systemic sclerosis.
|
Arthritis Rheumatol
|
2015
|
0.75
|
273
|
Binary segmentation masks can improve intrasubject registration accuracy of bone structures in CT images.
|
Ann Biomed Eng
|
2010
|
0.75
|
274
|
Strawberry gingivitis.
|
Joint Bone Spine
|
2012
|
0.75
|
275
|
Can ANCA differentiate eosinophilic granulomatosis with polyangiitis (Churg-Strauss) from idiopathic hypereosinophilic syndrome?
|
Clin Exp Rheumatol
|
2013
|
0.75
|
276
|
Sudden visual loss in a patient with microscopic polyangiitis.
|
Rheumatology (Oxford)
|
2009
|
0.75
|
277
|
Parathyroid Hormone is Related to Dysplasia and a Higher Rate of Distal Colorectal Adenoma in Women but Not Men.
|
Horm Cancer
|
2015
|
0.75
|
278
|
Gout mimicking rheumatoid arthritis.
|
Semin Arthritis Rheum
|
2016
|
0.75
|
279
|
Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
|
Ther Apher Dial
|
2008
|
0.75
|
280
|
Rheumatoid arthritis and multiple sclerosis: direful siblings, different strategies.
|
FEBS Lett
|
2011
|
0.75
|
281
|
Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.
|
JCI Insight
|
2017
|
0.75
|
282
|
The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome.
|
Arthritis Rheum
|
2009
|
0.75
|
283
|
Validation of a radiographic scoring system for haemochromatosis arthropathy.
|
Ann Rheum Dis
|
2010
|
0.75
|
284
|
Erratum: Reply to "Neutrophils are not required for resolution of acute gouty arthritis in mice".
|
Nat Med
|
2017
|
0.75
|
285
|
Clinical images: rheumatologic irony.
|
Arthritis Rheum
|
2007
|
0.75
|